Does Ischemic Preconditioning Require Reperfusion Before Index Ischemia?[∗]

Background: Ischemic preconditioning (IP) is initiated through one or several short bouts of ischemia and reperfusion which precede a prolonged ischemia. To test whether a reperfusion must precede the prolonged index ischemia, a series without reperfusion (intraischemic preconditioning: IIP) and a series with gradual onset of ischemia, i.e. ramp ischemia (RI), which is possibly related to the development of hibernation, was compared to conventional IP (CIP). Method: Experiments were performed an 27 blood-perfused rabbit hearts (Langendorff apparatus) that were randomized into one of four series: (1) control (n = 7): 60 min normal flow → 60 min low flow (10 %) ischemia → 60 min reperfusion. (2) CIP (n = 7): 4 times 5 min zero flow with 10 min reperfusion each → 60 min low flow (10 %) → ischemia 60 min reperfusion. (3) IIP (n = 7): 50 min normal flow → 10 min no flow → 60 min low flow (10 %) ischemia → 60 min reperfusion. (4) RI (n = 6): gradual reduction to 10 % flow during 60 min → 60 min low flow (10 %) ischemia → 60 min reperfusion. At the end of each protocol, the infarcted area was assessed. Results: The infarct area in control hearts was 6.7 ± 1.4 % (means ± SEM) of LV total area, in CIP hearts 2.6 ± 0.8 %, in IIP hearts 3.1 ± 0.5 %, and in RI hearts 3.0 ± 0.3 % (all p < 0.05 vs. control). The differences between the three protection protocols were statistically not significant, and no protective protocol reduced post-ischemic myocardial dysfunction. Conclusion: The preconditioning effect (infarct size reduction) appears not to depend on intermittent reperfusion. Thus, the protective mechanism of IP develops during the initial ischemia that precedes the index ischemia. Alternatively, low-flow ischemia is effectively a sort of reperfusion.

Key words:

Ischemic Preconditioning - Cardiac Surgery - Cardioprotection - Rabbit

1 Presented in part at the 64th Meeting of the German Cardiac Society, Mannheim, April 1998

References

• 1 Schaper W. Der aktuelle Stand der experimentellen Herzinfarktforschung.  Z Kardiol.. 1990;  79 811-8
• 2 Reimer K A, Lowe J E, Rasmussen M M, Jennings R B. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs. duration of coronary occlusion in dogs.  Circulation.. 1977;  56 786-94
• 3 Murry C E, Richard V J, Reimer K A, Jennings R B. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode.  Circ Res.. 1990;  66 913-31
• 4 van Winkle D M. Limitation of infarct size by myocardial ischemic preconditioning.  Basic Res Cardiol.. 1996;  91 38-40
• 5 Murry C E, Jennings R B, Reimer K A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.  Circulation.. 1986;  74 1124-36
• 6 Li G C, Vasquez B S, Gallagher K P, Lucchesi B R. Myocardial protection with preconditioning.  Circulation. 1990;  82 609-18
• 7 Schott R J, Rohmann S, Braun E R, Schaper J W. Ischemic preconditioning reduces infarct size in swine myocardium.  Circ Res.. 1990;  66 1133-42
• 8 Cohen M V, Liu G S, Downey J M. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits.  Circulation.. 1991;  84 341-9
• 9 Li Y W, Whittaker P, Kloner R A. The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventriculare arrhythmia.  Am Heart J.. 1992;  123 346-53
• 10 Yellon D M, Alkhulaifi A M, Pugsley W B. Preconditioning the human myocardium.  Lancet.. 1993;  342 276-7
• 11 Schulte H D. Intermittent coronary perfusion. In Piper HM, Preusse CJ, eds. Ischemia-reperfusion in cardiac surgery. Dordrecht, Boston, London; Kluwer Academic Publishers. 1993: 243-53
• 12 Abd-Elfattah A S, Ding M, Wechsler A S. Intermittent aortic crossclamping prevents cumulative adenosine triphosphate depletion, ventricular fibrillation, and dysfunction (stunning): is it preconditioning?.  J Thorac Cardiovasc Surg.. 1995;  110 328-39
• 13 Casthely P A, Shah C, Mekhjian H, Swistel D, Yoganathan T, Komer C, Miguelino R A, Rosales R. Left ventricular diastolic function after coronary artery bypass grafting: a correlative study with three different myocardial protection techniques.  J Thorac Cardiovasc Surg.. 1997;  114 254-60
• 14 Yellon D M, Baxter G F, Garcia-Dorado D, Heusch G, Sumeray M S. Ischaemic preconditioning: present position and future directions.  Cardiovasc Res.. 1998;  37 21-33
• 15 Ferrari R, Cargnoni A, Bernocchi P, Pasini E, Curello S, Ceconi C, Ruigrok T JC. Metabolic adaptation during a sequence of no-flow and low-flow ischemia.  Circulation. 1996;  94 2587-96
• 16 Schulz R, Post H, Sakka S, Wallbridge D R, Heusch G. Intraischemic preconditioning - Increased tolerance to sustained low-flow ischemia by a brief episode of no-flow ischemia without intermittent reperfusion.  Circ Res.. 1995;  76 942-50
• 17 Koning M MG, Simonis L AJ, de Zeeuw S, Nieukoop S, Post S, Verdouw P D. Ischaemic preconditioning by partial occlusion without intermittent reperfusion.  Cardiovasc Res.. 1994;  28 1146-51
• 18 Ovize M, Przyklenk K, Kloner R A. Partial coronary stenosis is sufficient and complete reperfusion is mandatory for preconditioning in the canine heart.  Circ Res.. 1992;  71 1165-73
• 19 Ito B R. Gradual onset of myocardial ischemia results in reduced myocardial infarction - Association with reduced contractile function and metabolic downregulation.  Circulation.. 1995;  91 2058-70
• 20 Arai A E, Grauer S E, Anselone C G, Pantely G A, Bristow J D. Metabolic adaptation to a gradual reduction in myocardial blood flow.  Circulation.. 1995;  92 244-52
• 21 Heusch G. Myocardial Hibernation.  Physiol Rev.. 1998;  78 1055-85
• 22 Brieden A, Schwanke U, Arnold G, Schipke J D. A computer program to acquire and process data from the experimental laboratory.  Eur J Physiol.. 1997;  433 (Suppl. 6) 410
• 23 Hale S L, Bellows S D, Hammerman H, Kloner R A. An adenosine A1 receptor agonist, R(-)-N-(2-phenylisopropyo-adenosine (PIA), but not adenosine itself, acts as a therapeutic preconditioning-mimetic agent in rabbits.  Cardiovasc Res.. 1993;  27 2140-5
• 24 Liu G S, Thornton J, van Winkle D M, Stanley A WH, Olsson R A, Downey J M. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart.  Circulation.. 1991;  84 350-6
• 25 Baxter G F, Goma F M, Yellon D M. Characterisation on the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardium.  Basic Res Cardiol.. 1997;  92 159-67
• 26 Cason B A, Gamperl A K, Slocum R E, Hickey R F. Anesthetic-induced preconditioning.  Anesthesiology.. 1997;  87 1182-90
• 27 Goto M, Miura M, Itoya M, Sakamoto J, Iimura O. Reduction of regional contractile function by preconditioning ischemia does not play a permissive role in the infarct size-limitation by the precontitioning.  Basic Res Cardiol.. 1993;  88 594-606
• 28 Toombs C F, Wiltse A L, Shebuski R J. Ischemic preconditioning fails to limit infarct size in reserpinized rabbit myocardium - Implication of norepine-phrine release in the preconditioning effect.  Circulation.. 1993;  88 2351-8
• 29 Noma S, Askenase A D, Agarwal J B, Helfant R H. The effect of changes in afterload an systolic bulging.  Circulation.. 1988;  77 221-6
• 30 Asimiakis G K, Inners-McBride K, Medellin G, Conti V R. Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart.  Am J Physiol.. 1992;  263 94
• 31 Kolocassides K G, Galinanes M, Hearse D J. Dichotomy of ischemic preconditioning: improved postischemic contractile function despite intensification of ischemic contracture.  Circulation.. 1996;  93 1725-33
• 32 Menasché P, Kevelaitis E, Mouas C, Grousset C, Piwnica A, Bloch G. Cardiopulmonary bypass, myocardial management, and support techniques.  J Thorac Cardiovasc Surg.. 1995;  110 1606-14
• 33 Valen G, Takeshima S, Vaage J. Preconditioning improves cardiac function after global ischemia, but not after cold cardioplegia.  Ann Thorac Surg.. 1996;  62 1397-403
• 34 Zellner J L, Hebbar L, Crawford F A, Mukherjee R, Spinale F G. Beneficial effects of myocyte preconditioning on contractile processes after cardioplegic arrest.  Ann Thorac Surg.. 1996;  61 558-64
• 35 Jenkins D P, Pugsley W B, Yellon D M. Ischaemic preconditioning in a model of global ischaemia: infarct size limitation, but no reeduction of stunning.  J Mol Cell Cardiol.. 1995;  27 1623-32
• 36 Ovize M, Przyklenk K, Hale S L, Kloner R A. Preconditioning does not attenuate myocardial stunning.  Circulation.. 1992;  85 2247-54
• 37 Gianella E, Mochmann H C, Levi R. Ischemic preconditioning prevents the impairment of hypoxic coronary vasodilatation caused by ischemia/reperfusion.  Circ Res.. 1997;  81 415-22
• 38 Walsh R S, Borges M, Thornton J D, Cohen M V, Downey J M. Hypoxia preconditions rabbit myocardium by an adenosine receptor-mediated mechanism.  Can J Cardiol.. 1995;  11 141-6
• 39 Koning M MG, Gho B CG, van Klaarwetter E, Duncker D J, Verdouw P D. Endocardial and epicardial infarct size after preconditioning by a partial coronary artery occlusion without intervening reperfusion. Importance of the degree and duration of flow reduction.  Cardiovasc Res.. 1995;  30 1017-27
• 40 Kapadia S J, Terlato J S, Most A S. Presence of a critical coronary artery stenosis does not abolish the protective effect of ischemic preconditioning.  Circulation.. 1997;  95 1286-92
• 41 Neely J R, Grotyohann L W. Role of glycolytic products in damage to ischemic myocardium. Dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts.  Circ Res.. 1984;  55 816-24
• 42 Deutsch E, Berger M, Kussmaul W G, Hirshfeld J W, Herrmann H C, Laskey W K. Adaptation to ischemia during percutaneous transluminal coronary angioplasty - clinical, hemodynamic, and metabolic features.  Circulation.. 1990;  82 2044-51
• 43 Kloner R A, Yellon D M. Does ischemic preconditioning occur in patients?.  J Am Coll Cardiol.. 1994;  24 1133-42
• 44 Tomai F, Crea F, Gaspardone A, Versaci F, Esposito C, Chiariello L, Gioffre P A. Mechanisms of cardiac pain during coronary angioplasty.  J Am Coll Cardiol.. 1993;  22 1892-6
• 45 Tomai F, Crea F, Gaspardone A, Versaci F, De Paulis R, Penta de Peppo A, Chiariello L, Gioffré P A. Ischaemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.  Circulation.. 1994;  90 700-5
• 46 Kloner R A, Shook T, Przyklenk K. et al . Previous angina alters in-hospital outcome in TIMI 4.  Circulation.. 1995;  91 37-47
• 47 Cave A C, Hearse D J. Ischemic preconditioning enhances postischemic function and reduces kreatine kinase leakage in the rat heart even when used in conjunction with hypothermic cardioplegia.  Circulation.. 1992;  86 (Suppl. 1) 31
• 48 van den Doel M A, Gho B CG, Duval S Y, Schoemaker R G, Duncker D J, Verdouw P D. Hypothermia extends the cardioprotection by ischaemic preconditioning to coronary artery occlusions of longer duration.  Cardiovasc Res.. 1998;  37 76-81
• 49 Fuster V, Badimon J J, Badimon L. Clinical-pathological correlations of coronary disease progression and regression.  Circulation.. 1992;  86 (Suppl. III) 11
• 50 Schulz R, Post H, Vahlhaus C, Heusch G. Ischemic preconditioning in pigs: a graded phenomenon.  Circulation.. 1998;  98 1022-9

1 Presented in part at the 64th Meeting of the German Cardiac Society, Mannheim, April 1998